Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Span LF"'
Publikováno v:
Critical Care; March 2008, Vol. 12 Issue: Supplement 2 p1-2, 2p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Märtson AG; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. a.martson@umcg.nl., da Silva Ferreira AR; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Veringa A; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Liu L; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Wardill HR; Adelaide Medical School, The University of Adelaide, Adelaide, Australia.; Precision Medicine (Cancer), South Australian Health and Medical Research Institute, Adelaide, Australia., Junier LAT; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van der Werf TS; Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Harmsen HJM; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Sturkenboom MGG; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Span LF; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Tissing WJE; Department of Pediatrics (Oncology and Hematology), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Princess Maxima Centre for Pediatric Oncology, Utrecht, The Netherlands., Alffenaar JC; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Westmead Hospital, Sydney, NSW, Australia.; Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW, Australia.
Publikováno v:
Annals of hematology [Ann Hematol] 2023 Feb; Vol. 102 (2), pp. 421-427. Date of Electronic Publication: 2023 Jan 17.
Autor:
Märtson AG; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands., Edwina AE; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands., Burgerhof JGM; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands., Berger SP; University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands., de Joode A; University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands., Damman K; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands., Verschuuren EAM; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands., Blokzijl H; University of Groningen, University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands., Bakker M; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, The Netherlands., Span LF; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, The Netherlands., van der Werf TS; University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands.; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands., Touw DJ; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands., Sturkenboom MGG; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands., Knoester M; University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, The Netherlands., Alffenaar JWC; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.; University of Sydney, Faculty of Medicine and Health, School of Pharmacy, New South Wales, Sydney, Australia.; Westmead Hospital, Westmead, New South Wales, Australia.; Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, New South Wales, Australia.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Aug 12; Vol. 76 (9), pp. 2356-2363.
Autor:
Veringa A; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Geling S; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Span LF; University of Groningen, University Medical Center Groningen, Department of Haematology, Groningen, The Netherlands., Vermeulen KM; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands., Zijlstra JG; University of Groningen, University Medical Center Groningen, Department of Critical Care, Groningen, The Netherlands., van der Werf TS; University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands., Kosterink JG; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; University of Groningen, Department of Pharmacy, Section of Pharmacotherapy and Pharmaceutical Care, Groningen, The Netherlands., Alffenaar JC; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Electronic address: j.w.c.alffenaar@umcg.nl.
Publikováno v:
International journal of antimicrobial agents [Int J Antimicrob Agents] 2017 Feb; Vol. 49 (2), pp. 243-246. Date of Electronic Publication: 2016 Nov 23.
Autor:
Veringa A; University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands., Ter Avest M; University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands., Span LF; University Medical Center Groningen, Department of Hematology, University of Groningen, Groningen, the Netherlands., van den Heuvel ER; Department of Mathematics and Computer Science, Eindhoven University of Technology, Eindhoven, the Netherlands., Touw DJ; University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands., Zijlstra JG; University Medical Center Groningen, Department of Critical Care, University of Groningen, Groningen, the Netherlands., Kosterink JG; University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.; University of Groningen, Department of Pharmacy, Section of Pharmacotherapy and Pharmaceutical Care, Groningen, the Netherlands., van der Werf TS; University Medical Center Groningen, Department of Internal Medicine, University of Groningen, Groningen, the Netherlands.; University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, University of Groningen, Groningen, the Netherlands., Alffenaar JC; University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands j.w.c.alffenaar@umcg.nl.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2017 Jan; Vol. 72 (1), pp. 261-267. Date of Electronic Publication: 2016 Sep 06.
Autor:
Chong GM; Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands g.chong@erasmusmc.nl., van der Beek MT; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., von dem Borne PA; Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands., Boelens J; Department of Microbiology, Ghent University Hospital, Ghent, Belgium., Steel E; Department of Haematology, Ghent University Hospital, Ghent, Belgium., Kampinga GA; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Span LF; Department of Haematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Lagrou K; Department of Microbiology and Immunology, KU Leuven-University of Leuven; University Hospitals Leuven, Leuven, Belgium., Maertens JA; Department of Microbiology and Immunology, KU Leuven-University of Leuven; Department of Haematology, University Hospitals Leuven, Leuven, Belgium., Dingemans GJ; PathoNostics B.V., Maastricht, The Netherlands., Gaajetaan GR; PathoNostics B.V., Maastricht, The Netherlands., van Tegelen DW; PathoNostics B.V., Maastricht, The Netherlands., Cornelissen JJ; Department of Haematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Vonk AG; Department of Medical Microbiology, Erasmus University Medical Center, Rotterdam, The Netherlands., Rijnders BJ; Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2016 Dec; Vol. 71 (12), pp. 3528-3535. Date of Electronic Publication: 2016 Aug 15.
Autor:
van Wanrooy MJ; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, †University of Groningen, University Medical Center Groningen, Department of Critical Care, and ‡University of Groningen, University Medical Center Groningen, Department of Hematology; §University of Groningen, University Medical Center Groningen, Division of Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy; and ¶University of Groningen, University Medical Center Groningen, Departments of Internal Medicine and Pulmonary Diseases and Tuberculosis, the Netherlands., Rodgers MG, Span LF, Zijlstra JG, Uges DR, Kosterink JG, van der Werf TS, Alffenaar JW
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2016 Jun; Vol. 38 (3), pp. 313-8.
Autor:
Schuurhuis JM; Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands., Span LF; Department of Hematology, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands., Stokman MA; Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands., van Winkelhoff AJ; Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands.; School of Dentistry and Oral Hygiene, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands., Vissink A; Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands., Spijkervet FK; Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands.
Publikováno v:
British journal of cancer [Br J Cancer] 2016 Apr 26; Vol. 114 (9), pp. 972-8. Date of Electronic Publication: 2016 Mar 22.